Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Ying Sun(Peking University), Wen-Fei Li(Sun Yat-sen University), Nian-Yong Chen(Sichuan University), Ning Zhang(First People's Hospital of Foshan), Guoqing Hu(Huazhong University of Science and Technology), Fang-Yun Xie(Sun Yat-sen University Cancer Center), Yan Sun(Peking University Cancer Hospital), Xiao-Zhong Chen(Zhejiang Cancer Hospital), Jin-Gao Li(Jiangxi Provincial Cancer Hospital), Xiao-Dong Zhu(Guangxi Medical University), Chaosu Hu(Fudan University Shanghai Cancer Center), Xiang-Ying Xu(Harbin Medical University), Yuanyuan Chen(Sun Yat-sen University), Wei-Han Hu(State Key Laboratory of Oncology in South China), Ling Guo(Sun Yat-sen University Cancer Center), Hao-Yuan Mo(State Key Laboratory of Oncology in South China), Lei Chen(Sun Yat-sen University Cancer Center), Yan-Ping Mao(Sun Yat-sen University), Rui Sun(Sun Yat-sen University), Ping Ai(Sichuan University), Shao-Bo Liang(First People's Hospital of Foshan), Guo-Xian Long(Tongji Hospital), Bao-Min Zheng(Peking University Cancer Hospital), Xing-Lai Feng(Zhejiang Cancer Hospital), Xiao-Chang Gong(Jiangxi Provincial Cancer Hospital), Ling Li(Guangxi Medical University), Chun-Ying Shen(Fudan University Shanghai Cancer Center), Jian-Yu Xu(Harbin Medical University), Ying Guo(State Key Laboratory of Oncology in South China), Yu‐Ming Chen(Zhejiang Cancer Hospital), Fan Zhang(Sun Yat-sen University Cancer Center), Li Lin(Sun Yat-sen University Cancer Center), Ling‐Long Tang(State Key Laboratory of Oncology in South China), Meng‐Zhong Liu(Sun Yat-sen University Cancer Center), Jun Ma(State Key Laboratory of Oncology in South China)
The Lancet Oncology
September 29, 2016
Cited by 947

Abstract


Related Papers

No related papers found

Powered by citation graph analysis